Research Article
Retrospective Study of Aging and Sex-Specific Risk Factors of COVID-19 with Hypertension in China
Table 3
Clinical characteristics and laboratory findings in different gender of hypertensive and non-hypertensive COVID-19 patients.
| | Characteristics | Total | Male | Female | value |
| | Patients with hypertension | () | () | () | | | Disease severity | | | | | | Mild | 16 (17.58%) | 3 (5.88%) | 13 (32.50%) | 0.06 | | General | 68 (74.73%) | 46 (90.20%) | 22 (55.00%) | | | Severe | 7 (7.69%) | 2 (3.92%) | 5 (12.50%) | | | Symptoms | | | | | | Fever | 39 (42.86%) | 27 (52.94%) | 12 (30.00%) | 0.04 | | Laboratory findings | | | | | | Hematocrit, % | 35.15 (13.34–42.78) | 38.48 (17.01–50.67) | 34.42 (5.11–45.67) | 0.032 | | Total bile acid, umol/L | 3.65 (2.30–7.23) | 2.75 (1.58–5.13) | 5.30 (3.05–7.98) | 0.004 | | Total protein, g/L | 66.40 (31.00–72.23) | 68.20 (63.70–75.20) | 62.90 (58.00–70.20) | 0.005 | | < 60 | 14 (15.38%) | 4 (7.84%) | 10 (25.00%) | 0.029 | | Globulin, g/L | 27.00 (24.30–30.45) | 28.30 (25.59–31.50) | 26.00 (22.00–28.61) | 0.011 | | Glucose, mmol/L | 5.62 (4.79–7.30) | 6.00 (4.85–8.47) | 5.04 (4.67–6.20) | 0.021 | | Cl, mmol/L | 102.05 (99.65–105.00) | 101.10 (99.06–103.85) | 103.16 (100.39–105.28) | 0.033 | | Fibrinogen, g/L | 3.31 (2.68–4.03) | 3.40 (2.97–4.55) | 2.69 (2.29–3.54) | 0.018 |
| | Patients without hypertension | () | () | () | | | Laboratory findings | | | | | | 5‘nuclease, U/L | 3.00 (2.25–6.40) | 3.03 (2.17–6.72) | 4.20 (3.00–7.60) | 0.044 | | Total bilirubin<5.13, umol/L | 43 (9.51%) | 14 (6.22%) | 28 (12.33%) | 0.038 | | Urea<3.2, mmol/L | 94 (20.80%) | 39 (17.33%) | 55 (24.23%) | 0.011 | | Cystatin C, mg/L | 1.00 (0.33–1.21) | 1.10 (0.37–1.30) | 0.97 (0.29–1.15) | 0.010 | | Urea/creatinine | 66.26 (47.20–78.86) | 52.68 (24.97–69.79) | 75.10 (53.24–96.09) | 0.021 | | Glomerular filtration rate | 110.31 (101.15–121.21) | 106.53 (99.33–122.52) | 115.70 (101.14–127.63) | 0.010 | | Eosinophil count, ×109 per L | | | | | | < 0.05 | 182 (40.27%) | 82 (36.44%) | 100 (44.05%) | 0.037 | | 0.05–0.3 | 155 (34.29%) | 86 (38.22%) | 69 (30.40%) | | | > 0.3 | 3 (0.66%) | 0 (0%) | 3 (1.32%) | | | Creatinine, umol/L | 62.00 (52.28–75.00) | 66.85 (56.49–78.00) | 61.81 (51.95–75.00) | <0.001 | | < 53 | 98 (21.68%) | 33 (14.67%) | 65 (28.63%) | <0.001 | | 53–97 | 266 (58.85%) | 142 (63.11%) | 124 (54.63%) | | | > 97 | 19 (4.20%) | 11 (4.89%) | 5 (2.20%) | | | Red blood cell distribution width SD, fL | | | | | | < 35 | 9 (1.99%) | 8 (3.56%) | 1 (0.44%) | 0.011 | | 35–56 | 325 (71.90%) | 158 (70.22%) | 167 (73.57%) | | | > 56 | 10 (2.21%) | 2 (8.89%) | 8 (3.52%) | |
|
|
